Company intelligence / Profile preview

Lumitron Technologies

Irvine, California, United Stateslumitronxrays.com ↗

Ownership: Private
Employees: ~50
Development stage: Preclinical

Overview

Recent demonstrations have shown the system can generate very high-energy electrons suitable for FLASH radiotherapy—delivering cancer-killing doses at rates that minimize damage to healthy tissue. The system also achieves x-ray imaging resolution up to 100x higher than conventional tubes, with much lower radiation dose. No formal clinical trial results published yet; initial deployments are in research hospitals/universities.

Therapeutic areas: Oncology
Modalities: Device (advanced x-ray and electron beam systems)Radiotherapy platform (enabling FLASH radiotherapy)
Industry: Medical Imaging

Partnerships

One of the world's largest commercial imaging groups

Beyond the preview

Go deeper on Lumitron Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lumitron Technologies.

Explore the full profile